AR008908A1 - Uso de loratadina y un descongestivo para preparar un medicamento para mejorar la funcion pulmonar de un paciente que padece asma - Google Patents

Uso de loratadina y un descongestivo para preparar un medicamento para mejorar la funcion pulmonar de un paciente que padece asma

Info

Publication number
AR008908A1
AR008908A1 ARP970105033A ARP970105033A AR008908A1 AR 008908 A1 AR008908 A1 AR 008908A1 AR P970105033 A ARP970105033 A AR P970105033A AR P970105033 A ARP970105033 A AR P970105033A AR 008908 A1 AR008908 A1 AR 008908A1
Authority
AR
Argentina
Prior art keywords
loratadine
improve
asthma
lung function
patient
Prior art date
Application number
ARP970105033A
Other languages
English (en)
Spanish (es)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AR008908A1 publication Critical patent/AR008908A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ARP970105033A 1996-10-31 1997-10-29 Uso de loratadina y un descongestivo para preparar un medicamento para mejorar la funcion pulmonar de un paciente que padece asma AR008908A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73966996A 1996-10-31 1996-10-31

Publications (1)

Publication Number Publication Date
AR008908A1 true AR008908A1 (es) 2000-02-23

Family

ID=24973307

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970105033A AR008908A1 (es) 1996-10-31 1997-10-29 Uso de loratadina y un descongestivo para preparar un medicamento para mejorar la funcion pulmonar de un paciente que padece asma

Country Status (21)

Country Link
EP (1) EP0941091A1 (no)
JP (1) JP2000505104A (no)
KR (1) KR20000052922A (no)
CN (1) CN1235545A (no)
AR (1) AR008908A1 (no)
AU (1) AU731756B2 (no)
BR (1) BR9712705A (no)
CA (1) CA2268546A1 (no)
CO (1) CO4910128A1 (no)
CZ (1) CZ150999A3 (no)
HU (1) HUP9904075A3 (no)
ID (1) ID23431A (no)
IL (1) IL129662A0 (no)
NO (1) NO992062D0 (no)
NZ (1) NZ335078A (no)
PE (1) PE11399A1 (no)
PL (1) PL333056A1 (no)
SK (1) SK54599A3 (no)
TR (1) TR199901003T2 (no)
WO (1) WO1998018470A1 (no)
ZA (1) ZA979731B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6270796B1 (en) * 1997-10-29 2001-08-07 Robert E. Weinstein Antihistamine/decongestant regimens for treating rhinitis
US6132758A (en) 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
IT1303671B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
AU6018899A (en) * 1998-09-10 2000-04-03 Schering Corporation Antihistamines for treating non-infective sinusitis or otitis media
US6521254B2 (en) 1998-12-07 2003-02-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
WO2000050015A1 (en) * 1999-02-23 2000-08-31 Yuhan Corporation Pharmaceutical capsule compositions containing loratadine and pseudoephedrine
KR100505899B1 (ko) * 1999-02-23 2005-08-01 주식회사유한양행 로라타딘과 슈도에페드린을 함유한 캅셀제 조성물
WO2000057880A1 (en) * 1999-03-29 2000-10-05 Schering Corporation Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine
AU2276801A (en) * 1999-12-20 2001-07-03 Schering Corporation Extended release oral dosage composition
SK287684B6 (sk) * 1999-12-20 2011-06-06 Schering Corporation Pevná orálna farmaceutická dávková forma s predĺženým uvoľňovaním
AU4248400A (en) * 2000-04-14 2001-10-30 J Med Pharmaceuticals Inc Single-dose antihistamine/decongestant formulations for treating rhinitis
AU2001264806A1 (en) * 2000-05-25 2001-12-03 Schering Corporation Stable liquid and solid formulations
BR0210534A (pt) * 2001-06-20 2004-06-22 Schering Corp Anti-histaminas para o tratamento de congestão nasal e obstrução nasal
NZ588134A (en) 2005-06-17 2010-11-26 Aft Pharmaceuticals Ltd Novel pharmaceutical for use in a method for treatment of upper respiratory mucosal congestion
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
TWI411451B (zh) * 2006-06-01 2013-10-11 Msd Consumer Care Inc 用於結腸吸收之脫羥腎上腺素醫藥調配物及組合物
KR101540191B1 (ko) * 2014-02-24 2015-07-28 성균관대학교산학협력단 로라타딘을 포함하는 항염증용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1110397A (en) * 1964-10-02 1968-04-18 Mead Johnson & Co Ephedrine composition
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5314697A (en) * 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine

Also Published As

Publication number Publication date
NO992062L (no) 1999-04-29
CZ150999A3 (cs) 1999-10-13
WO1998018470A1 (en) 1998-05-07
HUP9904075A3 (en) 2002-02-28
CO4910128A1 (es) 2000-04-24
BR9712705A (pt) 1999-10-26
PL333056A1 (en) 1999-11-08
AU731756B2 (en) 2001-04-05
EP0941091A1 (en) 1999-09-15
TR199901003T2 (xx) 1999-07-21
HUP9904075A2 (hu) 2000-05-28
JP2000505104A (ja) 2000-04-25
NO992062D0 (no) 1999-04-29
PE11399A1 (es) 1999-02-09
CA2268546A1 (en) 1998-05-07
SK54599A3 (en) 2000-08-14
ZA979731B (en) 1998-04-29
KR20000052922A (ko) 2000-08-25
IL129662A0 (en) 2000-02-29
CN1235545A (zh) 1999-11-17
NZ335078A (en) 2000-10-27
ID23431A (id) 2000-04-20
AU4995397A (en) 1998-05-22

Similar Documents

Publication Publication Date Title
AR008908A1 (es) Uso de loratadina y un descongestivo para preparar un medicamento para mejorar la funcion pulmonar de un paciente que padece asma
AR026610A1 (es) Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central
CL2004000675A1 (es) Uso de una combinacion de androgeno de origen biogenico o sintetico y un estrogeno de origen biogenico o sintetico para preparar un medicamento util en el tratamiento del hipogonadismo y enfermedades hipofisis o glandula pituitaria en hombres, para e
EE200300212A (et) Ravimite kombinatsioonid (näiteks kloorpromasiin ja pentamidiin) neoplastiliste haiguste raviks
CL2008003941A1 (es) Uso de escitalopram o de una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el tratamiento del desorden compulsivo obsesivo.
AR013742A1 (es) Metodo para el tratamiento de la hipercolesterolemia con polidialilamina no substituida
CL2009001279A1 (es) Compuestos derivados de nociceptina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del dolor (sol. divisional 2103-03).
AR005282A1 (es) Composición farmacéutica oral en la forma de un comprimido de unidades múltiples, uso de la misma para la preparación de medicamnetos, y procedimiento para su manufactura.
CO4520286A1 (es) Procedimiento para preparar clorhidrato de 1-(2 -desoxi-2 , 2 -difluoro-d-ribofuranosil)-4-aminopirimidin-2-ona
NO972211D0 (no) Sulfonamid-substituerte kromaner, deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende kromanene
NO990522L (no) Anvendelse av <beta>-ark mimetika som protease- og kinaseinhibatorer av transkripsjonsfaktorer
ATE333896T1 (de) Vaskularisierungsinhibitoren
ES2038650T3 (es) Procedimiento para preparar una composicion farmaceutica que comprende 3'-desoxitimidin-2'-eno-(3'-desoxi-2',3'-dideshidrotimidina) para tratar pacientes infectados con retrovirus.
AR011106A1 (es) COMPOSICIoN FARMACÉUTICA PARA EL TRAMIENTO O PREVENCI.ON DE LA DIABETES MELLITUS TIPO 2,
BR0107628A (pt) l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial
BRPI0304933B8 (pt) curativo de ferida, processo de manufatura do mesmo e uso do dito curativo de ferida para a manufatura de um medicamento para tratamento profilático e/ou curativo de uma condição médica
ATE451934T1 (de) Pharmazeutische zusammensetzung zur behandlung von rhinitiden
ES2188995T3 (es) Uso de un inhibidor de la h+, k+-atpasa en el tratamiento de los polipos nasales.
NO972433D0 (no) Substituerte 2-naftoylguanidiner, fremgangsmåter for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
DK34687A (da) Laegemiddel til nasal anvendelse, dets fremstilling og anvendelse
IT1317930B1 (it) Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patalogie associate ad una alterata attivazione
ES2191206T3 (es) Nueva utilizacion de la creatina.
ES2024695B3 (es) Proceso y dispositivo para la esterilizacion de los conductos de nebulizacion y/o alimentacion de aire de los instrumentos medicos, en especial instrumentos de cirujia dental.
AR014082A1 (es) Concentrado oral de sertralina
NO972434L (no) Substituerte 1-naftoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene

Legal Events

Date Code Title Description
FA Abandonment or withdrawal